Micheal L. Hebert is mentioned in a Life Sciences Intellectual Property Review article titled “Less is More: Patent Lawyers Flip the Script After Amgen.”
LINKS
Read “Less is More: Patent Lawyers Flip the Script After Amgen.” (subscription)
Micheal L. Hebert is mentioned in a Life Sciences Intellectual Property Review article titled “Less is More: Patent Lawyers Flip the Script After Amgen.”
LINKS
Read “Less is More: Patent Lawyers Flip the Script After Amgen.” (subscription)